We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+40.55%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.47B
AUM Growth
+$207M
Cap. Flow
-$137M
Cap. Flow %
-9.32%
Top 10 Hldgs %
9.07%
Holding
898
New
262
Increased
152
Reduced
230
Closed
245

Top Buys

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$9.29M
2
ZEN
ZENDESK INC
ZEN
+$9.24M
3
NTAP icon
NetApp
NTAP
+$8.82M
4
BFAM icon
Bright Horizons
BFAM
+$8.68M
5
LLY icon
Eli Lilly
LLY
+$8.53M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$31.8M
2
HUM icon
Humana
HUM
+$24.8M
3
EOG icon
EOG Resources
EOG
+$17.3M
4
DINO icon
HF Sinclair
DINO
+$9.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Healthcare 23.44%
3 Consumer Discretionary 13.66%
4 Industrials 10.93%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
26
Tesla
TSLA
$1.24T
$8.54M 0.58%
118,635
+105,105
+777% +$5.69M
PFPT
27
DELISTED
Proofpoint, Inc.
PFPT
$8.53M 0.58%
76,724
+4,619
+6% +$528K
WING icon
28
Wingstop
WING
$3.68B
$8.46M 0.58%
60,915
-1,885
-3% -$220K
COUP
29
DELISTED
Coupa Software Incorporated
COUP
$8.42M 0.57%
30,401
+27,944
+1,137% +$5.63M
CHGG icon
30
Chegg
CHGG
$108M
$8.38M 0.57%
124,659
+110,659
+790% +$5.91M
AXON
31
Axon Enterprise
AXON
$40.5B
$8.33M 0.57%
84,900
-42,800
-34% -$3.46M
REGN icon
32
Regeneron Pharmaceuticals
REGN
$68.8B
$8.3M 0.56%
13,304
-17,096
-56% -$9.7M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$121B
$8.27M 0.56%
+28,500
New +$7.73M
V icon
34
Visa
V
$677B
$8.21M 0.56%
42,509
-11,604
-21% -$2.12M
EXPD icon
35
Expeditors International
EXPD
$22.9B
$8.18M 0.56%
107,518
-19,688
-15% -$1.44M
ZTS icon
36
Zoetis
ZTS
$31.6B
$8.16M 0.56%
59,536
-7,895
-12% -$1.03M
MA icon
37
Mastercard
MA
$477B
$8.07M 0.55%
27,302
-8,003
-23% -$2.26M
SHW icon
38
Sherwin-Williams
SHW
$78.3B
$8.04M 0.55%
41,742
-14,427
-26% -$2.6M
TRU icon
39
TransUnion
TRU
$14.8B
$8.03M 0.55%
92,207
-24,608
-21% -$1.96M
NEWR
40
DELISTED
New Relic, Inc.
NEWR
$8.02M 0.55%
116,400
-71,163
-38% -$4.25M
RGEN icon
41
Repligen
RGEN
$7.44B
$8M 0.54%
64,721
+6,789
+12% +$799K
MNST icon
42
Monster Beverage
MNST
$91.4B
$7.96M 0.54%
229,662
-102,138
-31% -$3.33M
LII icon
43
Lennox International
LII
$18.8B
$7.95M 0.54%
+34,117
New +$6.89M
BN icon
44
Brookfield
BN
$102B
$7.95M 0.54%
451,356
+116
+0% +$2.04K
MRK icon
45
Merck
MRK
$324B
$7.93M 0.54%
107,533
+3,356
+3% +$253K
G icon
46
Genpact
G
$5.3B
$7.93M 0.54%
+217,256
New +$7.34M
GH icon
47
Guardant Health
GH
$19.5B
$7.93M 0.54%
+97,700
New +$7.87M
STZ icon
48
Constellation Brands
STZ
$22.2B
$7.91M 0.54%
45,210
-5,603
-11% -$933K
SGEN
49
DELISTED
Seagen Inc. Common Stock
SGEN
$7.9M 0.54%
+46,500
New +$6.94M
SIVB
50
DELISTED
SVB Financial Group
SIVB
$7.89M 0.54%
36,600
-23,210
-39% -$4.47M

Similar funds

PDT Partners's Q2 2020 Portfolio in Review

As of Q2 2020, PDT Partners held 898 positions worth $1.47B, up 16% from $1.26B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

PDT Partners withdrew a net $137M in Q2 2020, closing 245 positions and reducing 230 holdings. Its most notable exit was AbbVie, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ZENDESK INC worth $10.6M.

  • PDT Partners's largest Q2 2020 buy was ZENDESK INC: 119,997 shares worth $10.6M.
  • PDT Partners added most to Bloom Energy in Q2 2020, an estimated $9.29M increase.
  • PDT Partners's biggest Q2 2020 reduction was EOG Resources, cutting an estimated $17.3M.
  • PDT Partners fully exited AbbVie in Q2 2020, selling an estimated $31.8M.
  • PDT Partners's ten largest holdings make up 9.1% of its $1.47B portfolio in Q2 2020.
  • PDT Partners opened 262 new positions and closed 245 in Q2 2020.
  • PDT Partners's portfolio value rose 16% quarter-over-quarter to $1.47B.

Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.